DT.REAL ESTATE AG O.N./ DE0008055021 /
5/22/2024 8:16:05 AM | Chg. +0.100 | Volume | Bid9:20:00 AM | Ask9:20:00 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
7.900EUR | +1.28% | 0 Turnover: 0.000 |
7.900Bid Size: 32 | 8.950Ask Size: 0 | 162.6 mill.EUR | - | 7.67 |
GlobeNewswire
1:30 PM
Else Nutrition Products Now Available at Leading Natural Health Retailer, Marche Tau, in Quebec
Newsfile Corp
1:30 PM
CYduct Diagnostics Announces Participation in The Reg A & Crowdfunding Conference
Newsfile Corp
1:30 PM
Appia Announces Significant Results from Two Additional Exploration New Targets Electra and Maia at ...
GlobeNewswire
1:30 PM
Biogen Bolsters Late-Stage Pipeline, Expands Immunology Portfolio with Agreement to Acquire Human Im...
GlobeNewswire
1:30 PM
EverCommerce Announces an Increase and Extension of its Share Repurchase Program
GlobeNewswire
1:30 PM
Perma-Fix Announces Pricing of Approximately $20 Million Registered Direct Offering
GlobeNewswire
1:30 PM
Agrify Corporation Announces Approximately $13.8 Million Debt-to-Equity Conversion
GlobeNewswire
1:30 PM
MiNK Presents AgenT-797 Clinical Activity in Immune-Compromised Transplant Patient with Severe ARDS ...
GlobeNewswire
1:30 PM
Ollie’s Bargain Outlet Holdings, Inc. Announces First Quarter Fiscal 2024 Release Date and Conferenc...
GlobeNewswire
1:30 PM
BrightSpring Health Services Announces Recently Closed Acquisitions in Multiple Markets
GlobeNewswire
1:30 PM
Stock Yards Bancorp Declares Quarterly Cash Dividend of $0.30 Per Common Share
Newsfile Corp
1:00 PM
Flow Beverage Corp. to Present at Water Tower Research's Inaugural Consumer Products Virtual Investo...
GlobeNewswire
1:00 PM
Entero Therapeutics to Present Corporate Update at 2024 BIO International Convention